Home » Newsletters » BioWorld Asia

BioWorld Asia

July 21, 1999

View Archived Issues

Commission, Member States In New Clashes Over GMOs

New Gene Therapy Method Appears To Trigger Apoptosis

Proneuron Plans to Start Trials Of Macrophage CNS Therapy

Australians Use tRNA In New Approach To Gene Expression

Swiss Company Sulzer Medica Creating Biotech Division In U.S.

SR Pharma's Adjuvant Appears Beneficial In Phase II Trial

SmithKline Starts Phase IIb For Cantab's Warts Vaccine

France, Luxembourg Accused Of Violating EU Biotech Rules

Committee Recommends Against Genetic Testing In The Workplace

Gemini Licenses Osteoporosis Gene For Use By Affymetrix

Phytopharm Licenses Rights To Hepatitis B Compound

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...